Ardelyx, Inc.
ARDXNasdaqCIK 1437402HealthcareFiscal year ends Dec 31
Reports and events: 228 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1716:05 ET | 8-K | 8.01 Other events | 0001193125-26-354026 |
| 2026-08-0616:12 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437402-26-000044 |
| 2026-08-0616:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437402-26-000043 |
| 2026-07-0217:00 ET | 8-K | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437402-26-000033 |
| 2026-06-1717:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001437402-26-000029 |
| 2026-04-3016:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437402-26-000022 |
| 2026-04-3016:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437402-26-000021 |
| 2026-04-2916:01 ET | DEF 14A | Proxy statementPeriod 2026-06-16 | 0001140361-26-017800 |
| 2026-02-1916:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437402-26-000013 |
| 2026-02-1916:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437402-26-000012 |
| 2026-01-0808:34 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437402-26-000003 |
| 2025-12-1717:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437402-25-000021 |
| 2025-10-3016:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437402-25-000018 |
| 2025-10-3016:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437402-25-000016 |
| 2025-10-1408:27 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437402-25-000008 |
| 2025-08-0416:41 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-037464 |
| 2025-08-0416:22 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-25-037441 |
| 2025-07-0308:49 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-034132 |
| 2025-06-1817:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001628280-25-032172 |
| 2025-05-0116:04 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-021516 |
| 2025-05-0116:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-021514 |
| 2025-04-3007:47 ET | DEF 14A | Proxy statementPeriod 2025-06-18 | 0001140361-25-016522 |
| 2025-04-2908:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-25-020477 |
| 2025-02-2012:08 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-006653 |
| 2025-02-2007:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-006564 |
| 2025-01-1308:04 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-001246 |
| 2024-11-1816:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-048258 |
| 2024-10-3116:06 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-044551 |
| 2024-10-3116:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-044547 |
| 2024-10-0916:04 ET | 8-K | 1.01 Entry into a material agreement | 0001628280-24-042602 |
| 2024-08-1216:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-24-036749 |
| 2024-08-0116:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-034121 |
| 2024-08-0116:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-034110 |
| 2024-07-0207:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-030708 |
| 2024-06-1709:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-24-028413 |
| 2024-05-2316:58 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-024996 |
| 2024-05-0216:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-019990 |
| 2024-05-0216:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-019986 |
| 2024-04-2917:06 ET | DEF 14A | Proxy statementPeriod 2024-06-14 | 0001140361-24-023095 |
| 2024-03-0516:21 ET | 8-K | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-24-008908 |
| 2024-02-2216:40 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-006393 |
| 2024-02-2216:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-006321 |
| 2024-01-0808:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-000772 |
| 2023-11-1316:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-23-038599 |
| 2023-10-3107:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628280-23-035597 |
| 2023-10-3107:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-035596 |
| 2023-10-1816:14 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-23-034587 |
| 2023-10-1819:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-034537 |
| 2023-09-2517:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-032952 |
| 2023-08-0207:02 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001628280-23-026569 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.